AI Improves Endpoints and Evidence in Clinical Trials

December 17, 2025 00:31:50
AI Improves Endpoints and Evidence in Clinical Trials
The Big Unlock
AI Improves Endpoints and Evidence in Clinical Trials

Dec 17 2025 | 00:31:50

/

Show Notes

The Big Unlock · Gregory Goldmacher, M.D., Associate Vice President in Clinical Research, and Head of Clinical Imaging & Pathology, Merck Research Laboratories

In this episode, Dr. Greg Goldmacher, Associate VP of Clinical Research at Merck, known as MSD outside of the United States and Canada, explains how AI is transforming imaging, clinical trials, and early-stage drug development. Greg describes endpoints as the core of every clinical trial, since they determine whether a therapy is safe or effective. He notes that AI is not new to imaging and aligns well with pattern recognition, yet its real value lies in identifying details that humans often miss.

Greg stresses that drug development still depends on huge volumes of data spread across legacy systems. Without strong data standardization, AI cannot deliver reliable results. He also points to the FDA’s evolving guidance on AI and emphasizes the need for rigorous validation before using AI-derived measurements for regulatory decisions.

Greg highlights the opportunity to improve efficiency, reduce human burden, and generate more consistent insights. With thoughtful adoption, AI can support better decisions in clinical development and improve outcomes for patients. Take a listen.

Other Episodes

Episode 0

October 07, 2019 00:30:53
Episode Cover

Ed Marx: If you are a traditional CIO with a traditional mindset, you are going to be disrupted

In this special 25th episode, Ed Marx discusses his personal experience with two major health events over the past twelve months, and how information...

Listen

Episode 0

September 19, 2022 00:25:27
Episode Cover

David Evendon-Challis: Technology innovation is about combining unmet medical needs with unmet consumer needs

In this episode, David Evendon-Challis, Executive Board Member and Chief Scientific Officer at Bayer Consumer Health discusses their approach to help consumers adopt digital...

Listen

Episode

December 09, 2025 00:31:10
Episode Cover

Solving Healthcare’s Trilemma with Focus, Co-Innovation, and AI

The Big Unlock · Matthew Blosl, Chief Executive Officer, DexCare In this episode, Matthew Blosl, CEO of DexCare, discusses how he helps high-growth healthcare...

Listen